Pharmaceuticals

BD to acquire Edwards Lifesciences’ Critical Care Products Group for $4.2 billion

bexib
By bexib 0 Min Read

BD has announced that it is acquiring a provider of advanced surveillance solutions in an all-cash transaction.

You Might Also Like

APL and CurifyLabs Partner to Support Patients with 3D Printed Medical Technology

Phase 2 PREDICT-ILD Imaging Study in Interstitial Lung Disease Begins

New ways to determine drug value with health equity in mind

Melissa Krebs Shares Gersana’s Vision for Innovative Wound Care Solutions

Zongertinib demonstrates high objective response rates in previously treated advanced non-small cell lung cancer

Share This Article
Previous Article ‘A monster’: Biden slams asylum executive order plans
Next Article Bitcoin’s Beautiful Raging Bull Market With Crypto Waves’ Ryan Wilday
Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Stay Connected

Latest News

Cocktail trends for 2025 by Three Cents
Hospitality & Tourism
OCBC awards S$7.5 million in financial aid to junior employees in their second year
Fintech
Large-scale inference models accelerate content marketing
Retail & E-commerce
Selfridges ringing in the new year on the roof of San Carlo’s Alto
Hospitality & Tourism